Home > Boards > US Listed > Biotechs > Chembio Diagnostics (CEMI)

Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
XenaLives Member Profile
Member Level 
Followed By 367
Posts 49,166
Boards Moderated 29
Alias Born 09/20/01
160x600 placeholder
Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021 GlobeNewswire Inc. - 7/22/2021 5:03:53 PM
Chembio Diagnostics gets $4M HIV test purchase order Seeking Alpha - 7/22/2021 1:03:18 PM
Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund GlobeNewswire Inc. - 7/22/2021 12:49:39 PM
NeuroMetrix stock joins Reddit-driven rally with 60% rise in Q2 revenue Seeking Alpha - 7/22/2021 10:00:48 AM
Chembio Diagnostics Bags $28.3M Oder for SARS-CoV-2 Antigen Tests from Brazil TipRanks - 7/22/2021 2:53:30 AM
Chembio surges on purchase order for COVID—19 antigen test from Brazil Seeking Alpha - 7/21/2021 8:12:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2021 6:04:51 AM
Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil GlobeNewswire Inc. - 7/20/2021 10:56:14 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/19/2021 5:29:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 5:14:54 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/12/2021 8:30:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2021 5:21:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2021 4:06:31 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/13/2021 9:27:27 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/13/2021 9:26:04 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/7/2021 6:10:06 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 5:29:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 4:30:47 PM
Chembio Diagnostics EPS beats by $0.10, beats on revenue Seeking Alpha - 5/6/2021 4:28:28 PM
Chembio Diagnostics Reports First Quarter 2021 Financial Results GlobeNewswire Inc. - 5/6/2021 4:05:00 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2021 5:04:04 PM
Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021 GlobeNewswire Inc. - 4/22/2021 8:00:00 AM
Chembio announces U.S. launch of point-of-care-test to differentiate COVID-19 and Flu Seeking Alpha - 4/5/2021 10:28:43 AM
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu GlobeNewswire Inc. - 4/1/2021 5:30:00 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 3/15/2021 6:33:37 AM
XenaLives Member Level  Thursday, 10/08/20 10:56:15 AM
Re: None
Post # of 681 
Quote:

Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System
Oct 2, 2020
Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test System
Sep 8, 2020
Chembio Diagnostics Reports Second Quarter 2020 Financial Results
Aug 6, 2020
Chembio Diagnostics to Report Second Quarter 2020 Financial Results on August 6, 2020
Jul 23, 2020
Chembio Diagnostics Announces Preliminary Estimates of Second Quarter 2020 Revenues
Jul 6, 2020
Chembio Announces Plans to Seek EUA Approval from FDA for Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen System
Jul 6, 2020
Chembio Diagnostics Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System
Jul 6, 2020
Chembio to Report COVID-19 Product Development Plans and Preliminary Estimated Second Quarter 2020 Revenue Results
Jul 1, 2020
Chembio Diagnostics Receives FDA 510(k) Clearance for DPP Zika IgM System
Jun 8, 2020
Chembio Diagnostics Strengthens Commercial Organization
Jun 2, 2020




more...
http://chembio.com/investors/press-releases/



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences